AR107492A1 - Composición de desbridamiento para el tratamiento de heridas - Google Patents

Composición de desbridamiento para el tratamiento de heridas

Info

Publication number
AR107492A1
AR107492A1 ARP170100244A ARP170100244A AR107492A1 AR 107492 A1 AR107492 A1 AR 107492A1 AR P170100244 A ARP170100244 A AR P170100244A AR P170100244 A ARP170100244 A AR P170100244A AR 107492 A1 AR107492 A1 AR 107492A1
Authority
AR
Argentina
Prior art keywords
wound treatment
debridement
aqueous gel
debriding composition
mixture
Prior art date
Application number
ARP170100244A
Other languages
English (en)
Inventor
Deborah Hanah Bartfeld
Mery Kleyman
Dafna Geblinger
Eilon Asculai
Original Assignee
Mediwound Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediwound Ltd filed Critical Mediwound Ltd
Publication of AR107492A1 publication Critical patent/AR107492A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22031—Ananain (3.4.22.31)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22032—Stem bromelain (3.4.22.32)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Composiciones de desbridamiento en forma de un gel acuoso. Composición de desbridamiento que comprende una mezcla de enzimas proteolíticas obtenida a partir de bromelina presente en una forma seca, y un portador de gel acuoso, en el que, antes de su uso, la mezcla de enzimas proteolíticas se mezcla con el portador de gel acuoso para formar una composición de desbridamiento útil para el desbridamiento y el tratamiento de heridas.
ARP170100244A 2016-01-31 2017-01-31 Composición de desbridamiento para el tratamiento de heridas AR107492A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662289246P 2016-01-31 2016-01-31

Publications (1)

Publication Number Publication Date
AR107492A1 true AR107492A1 (es) 2018-05-02

Family

ID=59397670

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100244A AR107492A1 (es) 2016-01-31 2017-01-31 Composición de desbridamiento para el tratamiento de heridas

Country Status (16)

Country Link
US (1) US11382958B2 (es)
EP (1) EP3408387B1 (es)
JP (1) JP6952353B2 (es)
KR (1) KR102376345B1 (es)
CN (1) CN108884453B (es)
AR (1) AR107492A1 (es)
AU (1) AU2017211721B2 (es)
BR (1) BR112018015232A2 (es)
CA (1) CA3012299C (es)
ES (1) ES2909565T3 (es)
IL (1) IL260780B (es)
NZ (1) NZ745240A (es)
RU (1) RU2732224C9 (es)
TW (1) TWI758272B (es)
WO (1) WO2017130204A1 (es)
ZA (1) ZA201805489B (es)

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307081A (en) 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4226854A (en) 1974-01-08 1980-10-07 Gerold K. V. Klein Debridement of devitalized tissue with hydrolytic enzyme product
US4197291A (en) 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
US4329430A (en) 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4286064A (en) 1979-11-05 1981-08-25 Riker Laboratories, Inc. Process for isolating active debriding agent from bromelain
AU543965B2 (en) 1979-11-05 1985-05-09 Riker Laboratories, Inc. Method of enzymatic debridement
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
US4784653A (en) 1987-06-22 1988-11-15 Johnson & Johnson Patient Care, Inc. Absorbent adhesive dressing
GB8724728D0 (en) 1987-10-22 1987-11-25 Genzyme Corp Cysteine proteinase
US5271943A (en) 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
EP0618811B1 (en) 1991-12-03 2000-04-05 KLEIN, Gerold K. V. Proteolytic mixture containing escharase and method of isolating same
IL103969A (en) 1991-12-03 1997-01-10 Gerold K V Klein Proteolytic mixture containing escharase and method of isolating same
JPH08503691A (ja) 1992-06-30 1996-04-23 コーテックス リミテッド 下痢の治療における酵素、特にブロメラインの使用
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
GB9313188D0 (en) 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
US5387517A (en) 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5876992A (en) 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
JP4726296B2 (ja) 1998-02-27 2011-07-20 インスティチュート ストローマン アーゲー 創傷治癒のためのマトリックスタンパク質組成物
DK1096951T3 (da) 1998-07-15 2002-10-21 Ursapharm Arzneimittel Gmbh Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen
GB9819138D0 (en) 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
US6548556B2 (en) 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
RU2180856C1 (ru) 2001-02-08 2002-03-27 Гаврилюк Борис Карпович Средство для лечения ран
KR20030055442A (ko) 2001-12-26 2003-07-04 주식회사 참 존 다당체를 이용한 안정화 효소의 제조방법 및 이들 안정화효소가 첨가된 조성물
EP1539225B1 (en) 2002-04-23 2012-08-22 Mediwound, Ltd. Apparatus and methods for use in enzymatic escharotomy in burn induced compartment syndrome
EP1691745B1 (en) 2003-12-11 2011-02-02 Teikoku Pharma USA, Inc. Methods and compositions for treating skin wounds
ZA200701233B (en) 2004-07-13 2008-10-29 Mediwound Ltd Compositions and methods for dermatological wound healing
IL165334A0 (en) 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
CA2655067A1 (en) 2006-06-21 2007-12-27 Zazil Ortiz Barba Process for the production of bromelain by means of substances that induce proteins in pineapple plants established in vitro
WO2008021543A2 (en) 2006-08-17 2008-02-21 Monsanto Technology, Llc Transgenic plants with enhanced agronomic traits
RU2348396C2 (ru) 2006-12-18 2009-03-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Институт Федеральной службы безопасности Российской Федерации (г. Нижний Новгород)" (Институт ФСБ России) Композиция для лечения гнойных ран
EP2036978A1 (en) 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
WO2009100406A2 (en) * 2008-02-07 2009-08-13 Synta Pharmaceuticals Corp. Topical formulations for the treatment of psoriasis
DE202008001997U1 (de) * 2008-02-14 2008-04-03 Rosenberger Hochfrequenztechnik Gmbh & Co. Kg Kontaktfeder
CA2739243C (en) 2008-10-02 2017-08-22 L.R.R.& D. Ltd. Wound dressing comprising polymeric foam matrix and a hydrophilic polysaccharide disposed therein
DK3064217T3 (en) * 2009-01-06 2018-05-28 Galenagen Llc COMPOSITIONS COMPREHENSIVE PROTEASE, AMYLASE AND LIPASE FOR USE IN TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS
EP2373693A4 (en) 2009-01-06 2012-04-25 Curelon Llc COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF ORAL INFECTIONS BY E. COLI
WO2011017070A1 (en) 2009-07-28 2011-02-10 Merck Sharp & Dohme Corp. Methods for producing high concentration lyophilized pharmaceutical formulations
WO2012030750A2 (en) 2010-09-02 2012-03-08 Lubrizol Advanced Materials, Inc. Polymers and compositions
ES2690568T3 (es) 2011-07-20 2018-11-21 Mediwound, Ltd. Extracto proteolítico de bromelaína para el tratamiento de trastornos del tejido conectivo
EP3659630B1 (en) 2013-03-15 2023-12-27 Smith & Nephew, Inc. Dissolvable gel-forming film for delivery of active agents
CN103285383B (zh) 2013-06-03 2015-01-07 海南通用同盟药业有限公司 一种包含菠萝蛋白酶的药物组合物及菠萝蛋白酶肠溶片
US9592280B2 (en) 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
CN105213107A (zh) * 2015-08-24 2016-01-06 泰州市榕兴医疗用品股份有限公司 一种菠萝酶凝胶敷料
KR102376363B1 (ko) 2016-04-18 2022-03-21 메디운드 리미티드 만성 상처의 괴사조직제거 방법

Also Published As

Publication number Publication date
EP3408387A4 (en) 2019-11-13
AU2017211721A1 (en) 2018-08-30
AU2017211721B2 (en) 2022-01-13
KR102376345B1 (ko) 2022-03-18
US20190030140A1 (en) 2019-01-31
JP6952353B2 (ja) 2021-10-20
TW201729834A (zh) 2017-09-01
NZ745240A (en) 2022-12-23
ZA201805489B (en) 2019-11-27
CA3012299C (en) 2022-05-31
JP2019508392A (ja) 2019-03-28
US11382958B2 (en) 2022-07-12
RU2732224C2 (ru) 2020-09-14
RU2018129438A3 (es) 2020-05-25
ES2909565T3 (es) 2022-05-09
CN108884453A (zh) 2018-11-23
EP3408387B1 (en) 2022-01-05
WO2017130204A1 (en) 2017-08-03
RU2018129438A (ru) 2020-03-02
RU2732224C9 (ru) 2021-06-18
BR112018015232A2 (pt) 2018-12-26
CN108884453B (zh) 2022-07-29
TWI758272B (zh) 2022-03-21
CA3012299A1 (en) 2017-08-03
IL260780B (en) 2021-02-28
KR20180104138A (ko) 2018-09-19
EP3408387A1 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
CL2018000106A1 (es) Moléculas de anticuerpo que se unen a cd45
CL2017001488A1 (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
CL2016001547A1 (es) Composiciones para el cuidado oral
GT201400043A (es) Imidazopiridazinas sustituidas con amino
CL2016000507A1 (es) Hidrogel que comprende los grupos 1, 2-diol o 1, 3-diol acetilados con una especie radiopaca; composición que comprende un hidrogel; método para realizar un polímero radiopaco; método para formar una microesfera de hidrogel radiopaca; y uso de hidrogel o composición.
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
EA201591474A1 (ru) Модуляторы метил-модифицирующих ферментов, композиции и их применение
CO2019004643A2 (es) Plastificante para geopolímeros
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
EA201390260A1 (ru) Композиция для ухода за волосами
UY33917A (es) ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?.
CL2015002433A1 (es) Imidazopiridazinas sustituidas
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
EA201791749A1 (ru) Инкапсуляция высокоэффективных активных агентов
BR112017011476A2 (pt) composição baseada em aminoácidos para recuperação de fibroelastina em tecidos conjuntivos dérmicos e uso
AU201611010S (en) Mixer
CL2019001397A1 (es) Estabilidad mejorada de composiciones que contienen inhibidor de la ureasa.
AR107493A1 (es) Métodos de desbridamiento de heridas crónicas
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
EA201891033A1 (ru) Композиция с благоприятным действием на кожу на основе растворителя, содержащего гидроксигруппы
PH12016501387A1 (en) Method of enhancing the dry grinding efficiency of petcoke
GT201500340A (es) Una composición, proceso y un kit para el procesamiento del azúcar
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
AR107492A1 (es) Composición de desbridamiento para el tratamiento de heridas
EA201791437A1 (ru) Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы